LONG INDUCTION OF DRUG TOLERANCE TO ETHAMBUTOL IN TREATMENT OF MYCOBACTERIUM AVIUM COMPLEX LUNG DISEASE

被引：0
|
作者：
Mahajan, A.
Labib, E.
Shubeilat, J.
Gonzalez-Estrada, A.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2023年 / 131卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
M028
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [1] Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease
    Griffith, DE
    Brown-Elliott, BA
    Shepherd, S
    McLarty, J
    Griffith, L
    Wallace, RJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (02) : 250 - 253
  • [2] Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine
    Field, SK
    Cowie, RL
    CHEST, 2003, 124 (04) : 1482 - 1486
  • [3] In Vitro MIC Values of Rifampin and Ethambutol and Treatment Outcome in Mycobacterium avium Complex Lung Disease
    Kwon, Byoung Soo
    Kim, Mi-Na
    Sung, Heungsup
    Koh, Younsuck
    Kim, Woo-Sung
    Song, Jin-Woo
    Oh, Yeon-Mok
    Lee, Sang-Do
    Lee, Sei Won
    Lee, Jae-Seung
    Lim, Chae-Man
    Choi, Chang-Min
    Huh, Jin-Won
    Hong, Sang-Bum
    Park, Sojung
    Shim, Tae Sun
    Chong, Yong Pil
    Jo, Kyung-Wook
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (10)
  • [4] Therapeutic Drug Monitoring in the Treatment of Mycobacterium avium Complex Lung Disease
    Koh, Won-Jung
    Jeong, Byeong-Ho
    Jeon, Kyeongman
    Lee, Soo-Youn
    Shin, Sung Jae
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 186 (08) : 797 - 802
  • [5] Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
    Kim, Hyung-Jun
    Lee, Jong Sik
    Kwak, Nakwon
    Cho, Jaeyoung
    Lee, Chang-Hoon
    Han, Sung Koo
    Yim, Jae-Joon
    BMC PULMONARY MEDICINE, 2019, 19 (01)
  • [6] Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
    Hyung-Jun Kim
    Jong Sik Lee
    Nakwon Kwak
    Jaeyoung Cho
    Chang-Hoon Lee
    Sung Koo Han
    Jae-Joon Yim
    BMC Pulmonary Medicine, 19
  • [7] Treatment for Mycobacterium avium complex lung disease
    Pan, Sheng-Wei
    Shu, Chin-Chung
    Feng, Jia-Yih
    Su, Wei-Juin
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 : S67 - S75
  • [8] Treatment Outcomes after Discontinuation of Ethambutol due to Adverse Events in Mycobacterium avium Complex Lung Disease
    Kwon, Yong Shik
    Kwon, Byoung Soo
    Kim, Ock-hwa
    Park, Yea Eun
    Shim, Tae Sun
    Chong, Yong Pil
    Jo, Kyung-Wook
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (09)
  • [9] Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease
    Moon, Seong Mi
    Yoo, In Young
    Huh, Hee Jae
    Lee, Nam Yong
    Jhun, Byung Woo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (01)
  • [10] SUPERIORITY OF ENVIOMYCIN OR STREPTOMYCIN OVER ETHAMBUTOL IN INITIAL TREATMENT OF LUNG-DISEASE CAUSED BY MYCOBACTERIUM-AVIUM COMPLEX
    TSUKAMURA, M
    ICHIYAMA, S
    MIYACHI, T
    CHEST, 1989, 95 (05) : 1056 - 1058
12345